Earnings Analyzer
Stock earnings page

RESMED INCORPORATED (RMD)

Track the next or latest earnings date for RESMED INCORPORATED, review consensus estimates, and see cached AI analysis for recent quarterly results.

Recent earnings news

Resmed's Q4 Earnings on Deck: What's in Store for the Stock? — TradingView News
www.tradingview.com · 2026-07-31T13:32:00

Resmed RMD is set to release fourth-quarter fiscal 2026 results on Aug. 6, after the closing bell.The renowned sleep health device maker posted adjusted earnings per share (EPS) of $2.86 in the last reported quarter, surpassing the Zacks Consensus Estimate by 2.51%. The company topped earnings ...

BankChampaign National Association Acquires New Shares in ResMed Inc. $RMD - Defense World
defenseworld.net · 2026-07-31T08:35:04

BankChampaign National Association acquired a new stake in shares of ResMed Inc. (NYSE:RMD – Free Report) during the first quarter, according to its most recent filing with the SEC. The fund acquired 2,981 shares of the medical equipment provider’s stock, valued at approximately $669,000.

3 Large-Cap Stocks to Consider Right Now - StockStory
stockstory.org · 2026-07-31T04:40:41

Founded in 1989 to address the ... (NYSE:RMD) develops cloud-connected medical devices and software solutions that treat sleep apnea, COPD, and other respiratory disorders for home and clinical use. ... Average constant currency growth of 9.1% over the past two years demonstrates its ability to grow…

REDDIT ($RDDT) Releases Q2 2026 Earnings | RDDT Stock News
quiverquant.com · 2026-07-30T20:32:47

REDDIT ($RDDT) posted quarterly earnings results for Q2 2026 on Thursday, July 30th. The company reported earnings of $1.25 per share, beating estimates of $0.97 by $0.28. The company also reported revenue of $804,910,000, beating estimates of $744,860,263 by $60,049,737.Stock price change ...

ResMed (RMD) Could Be 14% Undervalued On Its Sleep Health Growth Story - Simply Wall St News
simplywall.st · 2026-07-29T22:19:14

ResMed stock performance and business snapshot ResMed (RMD) has drawn investor attention after recent share price gains over the past week and month, set against weaker returns over the past year and year to date. The stock last closed at US$214.29, giving the company a market value of about ...

Upcoming earnings date

Aug 06, 2026

After-hours

Fiscal quarter: 2026-06-30

EPS estimate: $2.90

Revenue estimate: N/A

Market cap: $30.25B

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week
Date Quarter Report window EPS est. Revenue est.
Aug 06, 2026 2026-06-30 After-hours $2.90 N/A